Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Close Up Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Close Up Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Part 2: Close Up Radio Welcomes Back Computational Biology Expert Dr. Eric Thomson-Wasiolek

31:30
 
Share
 

Manage episode 490840762 series 2906244
Content provided by Close Up Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Close Up Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Castro Valley, CA – It is a known fact that advances in medicine are occurring all the time, and more rapidly than ever. Whether it’s the discovery of new ailments, and especially the treatments to counter these ailments, it seems that the only constant is change. Our guest is a proponent of what he calls a “revolutionary new area of science,” that will drastically improve medicine as we know it. He will discuss what this science is, along with its applications. This is the perspective and expertise of Dr. Eric Thomson-Wasiolek.

Dr. Eric Thomson-Wasiolek is an expert in the field of computational biology and a proponent in the use and application of machine learning to synthetic biology. He was recently inducted into Who’s Who in America. You can look him up by simply googling “Eric Wasiolek.”

“In my earlier career I worked in the computer industry – primarily in networking and database,” Dr. Thomson-Wasiolek recalls. “I worked in an area called heterogeneous distributed computing where you have software that runs on multiple computers connected through a network. Those computers are from different vendors running different operating systems – storing and retrieving information to and from these multiple machines. Most of my career was in product marketing which is between engineering and sales. You help define the future products. Along the way, I earned a Master’s in Computational Molecular Biology, which combines mathematics and computer science with molecular biology and a Doctorate in Computer Science and an MBA. The Master’s Thesis was done at Stanford.”

“This has been relevant to the direction that I have been going,” he adds. “While I am retired, I will consider coming out of retirement for a significant job opportunity in Biotech applying machine learning to synthetic biology. Understand that applying machine learning to synthetic biology IS a computational biology revolution. Companies should be interested in this technology as it will both decrease research costs and accelerate generating additional revenues through new products.”

For these two interviews, Dr. Thomson-Wasiolek will discuss what machine learning is and applying machine learning to synthetic biology and its applications in science and medicine. “There’s a whole revolution happening in that area,” he declares, “representing the future of technology.”

Regarding machine learning, there is often a misconception as to how similar and different it is to artificial intelligence, “Machine learning is only a fraction of what artificial intelligence is about – perhaps only one-tenth of it,” Dr. Thomson-Wasilek clarifies. “There are many areas of artificial intelligence and computational biology which don’t use machine learning.” And of course, many areas of computing don’t use AI or machine learning at all.

“You are taking data and finding patterns in the data to produce outputs and make predictions,” he adds. “Machine learning is not programmed but trained.”

“Synthetic biology is the field and industry where biological entities are modified or created de novo,” Dr. Thomson-Wasiolek defines. “Examples are creating new genes as with genetic engineering, new proteins, or modifying a living organism such as a bacterium.”

Some aspects of synthetic biology simply include pathway engineering, bio-parts, genetic circuits, cell free systems, DNA databases, nano-robots, reprogramming cells, computational protein design, reprogramming aging, and genetically modified organisms.

“One practical application of machine learning to synthetic biology is the acceleration of drug discovery,” Dr. Thomson-Wasiolek shares. “Another application is the use of medical imaging to verify a tumor in a certain tissue. You can take a medical image and run it through a machine learning program that performs object recognition. Cancer is a genetic disease, and you can use machine learning to determine mutations in gene sequences that cause the cancer” and then direct a tool like the protein CRISPR to excise the malignant gene curing a genetic disease like Sickle Cell Anemia.”

While there are medical applications and research, there are also non-medical applications such as performing overall biological research. It can be used to research more about any organism including human beings.

“Machine learning and synthetic biology are only dangerous if you are using it to create biological weapons,” Dr. Thomson-Wasiolek assures. “In addition, COVID was not a use of synthetic biology but instead created by nature. It was synthetic biology that created the mRNA vaccine.”

“Learn what machine learning AI and synthetic biology are really about,” concludes Dr. Thomson-Wasiolek. “It will really change the future.”

  continue reading

301 episodes

Artwork
iconShare
 
Manage episode 490840762 series 2906244
Content provided by Close Up Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Close Up Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Castro Valley, CA – It is a known fact that advances in medicine are occurring all the time, and more rapidly than ever. Whether it’s the discovery of new ailments, and especially the treatments to counter these ailments, it seems that the only constant is change. Our guest is a proponent of what he calls a “revolutionary new area of science,” that will drastically improve medicine as we know it. He will discuss what this science is, along with its applications. This is the perspective and expertise of Dr. Eric Thomson-Wasiolek.

Dr. Eric Thomson-Wasiolek is an expert in the field of computational biology and a proponent in the use and application of machine learning to synthetic biology. He was recently inducted into Who’s Who in America. You can look him up by simply googling “Eric Wasiolek.”

“In my earlier career I worked in the computer industry – primarily in networking and database,” Dr. Thomson-Wasiolek recalls. “I worked in an area called heterogeneous distributed computing where you have software that runs on multiple computers connected through a network. Those computers are from different vendors running different operating systems – storing and retrieving information to and from these multiple machines. Most of my career was in product marketing which is between engineering and sales. You help define the future products. Along the way, I earned a Master’s in Computational Molecular Biology, which combines mathematics and computer science with molecular biology and a Doctorate in Computer Science and an MBA. The Master’s Thesis was done at Stanford.”

“This has been relevant to the direction that I have been going,” he adds. “While I am retired, I will consider coming out of retirement for a significant job opportunity in Biotech applying machine learning to synthetic biology. Understand that applying machine learning to synthetic biology IS a computational biology revolution. Companies should be interested in this technology as it will both decrease research costs and accelerate generating additional revenues through new products.”

For these two interviews, Dr. Thomson-Wasiolek will discuss what machine learning is and applying machine learning to synthetic biology and its applications in science and medicine. “There’s a whole revolution happening in that area,” he declares, “representing the future of technology.”

Regarding machine learning, there is often a misconception as to how similar and different it is to artificial intelligence, “Machine learning is only a fraction of what artificial intelligence is about – perhaps only one-tenth of it,” Dr. Thomson-Wasilek clarifies. “There are many areas of artificial intelligence and computational biology which don’t use machine learning.” And of course, many areas of computing don’t use AI or machine learning at all.

“You are taking data and finding patterns in the data to produce outputs and make predictions,” he adds. “Machine learning is not programmed but trained.”

“Synthetic biology is the field and industry where biological entities are modified or created de novo,” Dr. Thomson-Wasiolek defines. “Examples are creating new genes as with genetic engineering, new proteins, or modifying a living organism such as a bacterium.”

Some aspects of synthetic biology simply include pathway engineering, bio-parts, genetic circuits, cell free systems, DNA databases, nano-robots, reprogramming cells, computational protein design, reprogramming aging, and genetically modified organisms.

“One practical application of machine learning to synthetic biology is the acceleration of drug discovery,” Dr. Thomson-Wasiolek shares. “Another application is the use of medical imaging to verify a tumor in a certain tissue. You can take a medical image and run it through a machine learning program that performs object recognition. Cancer is a genetic disease, and you can use machine learning to determine mutations in gene sequences that cause the cancer” and then direct a tool like the protein CRISPR to excise the malignant gene curing a genetic disease like Sickle Cell Anemia.”

While there are medical applications and research, there are also non-medical applications such as performing overall biological research. It can be used to research more about any organism including human beings.

“Machine learning and synthetic biology are only dangerous if you are using it to create biological weapons,” Dr. Thomson-Wasiolek assures. “In addition, COVID was not a use of synthetic biology but instead created by nature. It was synthetic biology that created the mRNA vaccine.”

“Learn what machine learning AI and synthetic biology are really about,” concludes Dr. Thomson-Wasiolek. “It will really change the future.”

  continue reading

301 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play